The rationale for nonsteroidal anti-inflammatory drug therapy for inflammatory myofibroblastic tumors: A Children's Oncology Group study

Journal of Pediatric Surgery

Volumn 40, Issue 6, 2005, Pages 999-1003

  Applebaum, Harry ^a   Kieran, Mark W ^b   Cripe, Timothy P ^c   Coffin, Cheryl M ^d   Collins, Margaret H ^c   Kaipainen, Arja ^e   Laforme, Andrea ^e   Shamberger, Robert C ^e  

^a KAISER PERMANENTE MEDICAL CENTER   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

^d PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

^e BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

ALK 1 gene; Cyclooxygenase 2 (COX 2); Inflammatory myofibroblastic tumor (IMT); Nonsteroidal anti inflammatory drug (NSAID); Vascular endothelial growth factor (VEGF)

Indexed keywords

CYCLOOXYGENASE 2; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN; PROTEIN ALK1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CHILDHOOD CANCER; DRUG MECHANISM; DRUG USE; ENZYME INHIBITION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PLASMA CELL GRANULOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR VASCULARIZATION;

ACTIVIN RECEPTORS, TYPE II; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE 2; GENE EXPRESSION; HUMANS; MEMBRANE PROTEINS; NEOPLASMS, MUSCLE TISSUE; NEOVASCULARIZATION, PATHOLOGIC; RETROSPECTIVE STUDIES; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 20544443165     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2005.03.016     Document Type: Article

References (22)

1. B.M. Sanders, K.W. West, and C. Gingalewski Inflammatory pseudotumor of the alimentary tract: clinical and surgical experience J Pediatr Surg 36 2001 169 173
2. W. Su, A. Ko, and T.O. Connell Treatment of pseudotumors with non-steroidal anti-inflammatory drugs J Pediatr Surg 35 2000 1635 1637
3. C.M. Coffin, L.P. Dehner, and J.M. Meis-Kindblom Inflammatory myofibroblastic tumor, inflammatory fibrosarcoma, and related lesions: an historical review with differential diagnostic considerations Semin Diagn Pathol 15 1998 102 110
4. C.M. Coffin, A. Patel, and S. Perkins ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor Mod Pathol 14 2001 569 576
5. C.M. Coffin, and J.A. Fletcher Inflammatory myofibroblastic tumor C.D.M. Fletcher K.K. Unni F. Mertens Pathology and genetics of tumours of soft tissue and bone. World Health Organization Classification of Tumours 2002 IARC Press Lyon 91 93
6. C.M. Coffin, J. Watterson, and J.R. Priest Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor): a clinicopathologic and immunohistochemical study of 84 cases Am J Surg Pathol 19 1995 859 872
7. L.P. Dehner, and C.M. Coffin Idiopathic fibrosclerotic disorders and other inflammatory pseudotumors Semin Diagn Pathol 15 1998 161 173
8. D.S. Dickens, R. Kozielski, and J. Khan Cyclooxygenase-2 expression in pediatric sarcomas Pediatr Dev Pathol 5 2002 356 364
9. M. Sonoshita, K. Takaku, and M. Oshima Cyclooxygenase-2 expression in fibroblasts and endothelial cells of intestinal polyps Cancer Res 62 2002 6846 6849
10. S. Miura, A. Tatsuguchi, and K. Wada Cyclooxygenase-2-regulated vascular endothelial growth factor release in gastric fibroblasts Am J Physiol Gastrointest Liver Physiol 287 2004 G444 G451
11. M.R. Raspollini, G. Amunni, and A. Villanucci COX-2 status in relation to tumor microvessel density and VEGF expression: analysis in ovarian carcinoma patients with low versus high survival rates Oncol Rep 11 2004 309 313
12. S. Yoshida, H. Amano, and I. Hayashi COX-2/VEGF-dependent facilitation of tumor-associated angiogenesis and tumor growth in vivo Lab Invest 83 2003 1385 1394
13. W.K. Leung, K.F. To, and M.Y. Go Cyclooxygenase-2 upregulates vascular endothelial growth factor expression and angiogenesis in human gastric carcinoma Int J Oncol 23 2003 1317 1322
14. Y.E. Joo, J.S. Rew, and Y.H. Seo Cycooxygenase-2 overexpression correlates with vascular endothelial growth factor expression and tumor angiogenesis in gastric cancer J Clin Gastroenterol 37 2003 28 33
15. K. Kirkpatrick, W. Ogunkolade, and A. Elkak The mRNA expression of cyclo-oxygenase-2 (COX-2) and vascular endothelial growth factor (VGF) in human breast cancer Curr Med Res Opin 18 2002 237 241
16. E. Niederberger, C. Manderscheid, and S. Grosch Effects of the selective COX-2 inhibitors celecoxib and rofecoxib on human vascular cells Biochem Pharmacol 68 2004 341 350
17. M. Tamura, S. Sebastian, and B. Gurates Vascular endothelial growth factor up-regulates cyclooxygenase-2 expression in human endothelial cells J Clin Endocrinol Metab 87 2002 3504 3507
18. K.M. Leahy, R. Ornberg, and Y. Wang Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo Cancer Res 62 2002 625 631
19. H. Parfenova, V.N. Parfenov, and B.V. Shlopov Dynamics of nuclear localization sites for COX-2 in vascular endothelial cells Am J Physiol Cell Physiol 281 2001 C166 C178
20. M.A. Hull, J.L. Thompson, and C.J. Hawkey Expression of cyclooxygenase 1 and 2 by human gastric endothelial cells Gut 45 1999 529 536
21. C. Creminon, A. Habib, and J. Maclour Differential measurement of constitutive (COX-1) and inducible (COX-2) cyclooxygenase expression in human umbilical vein endothelial cells using specific immunometric enzyme immunoassays Biochim Biophys Acta 1254 1995 341 348
22. M. Tamura, S. Sbastian, and B. Gurates Vascular endothelial growth factor up-regulates cyclooxygenase-2 expression in human endothelial cells J Clin Endocrinol Metab 87 2002 3504 3507